AstraZeneca Buys 250,000 Own Shares to Cancel
22 August 2012 - 9:25AM
Dow Jones News
LONDON--AstraZeneca PLC (AZN.LN), a global research-based
biopharmaceutical company, said Wednesday that Aug. 21, it
purchased for cancellation 250,000 ordinary shares of AstraZeneca
PLC at a price of 2987 pence per share.
AstraZeneca PLC shares closed Tuesday at GBP29.82, valuing the
company at GBP37.24 billion.
-Write to Razak Musah Baba at razak.baba@dowjones.com
Subscribe to WSJ: http://online.wsj.com?mod=djnwires